·
3 Min Read

July 31, 2020: State Advocacy Update

Providing individualized pain care during COVID-19 in West Virginia and more in the latest State Advocacy Update.

Advocacy Update
Figure sitting on park bench
·
5 Min Read

Nation’s drug overdose epidemic requires new policy focus

The nation’s overdose epidemic is being increasingly fueled by illicitly manufactured fentanyl, psychostimulants, heroin, cocaine and drug combinations.

Behavioral Health
·
1 Min Read

AMA applauds FDA for requiring naloxone information on opioid labels

The new labeling can serve as a starting point for discussion between patients and physicians about risks and benefits associated with opioids.

Press Releases
·
5 Min Read

AMA report shows evolving, deadlier overdose epidemic

AMA cites need to remove barriers to evidence-based care for patients with pain or a substance use disorder.

Press Releases
·
4 Min Read

AMA expands online education hub to streamline needs of physicians

AMA Ed Hub™ features new educational content, auto-reporting from partners.

Press Releases
·
5 Min Read

July 10, 2020: State Advocacy Update

AMA urges all states to follow Michigan effort to increase access to naloxone and more in the latest State Advocacy Update.

Advocacy Update
UPDATED
·
5 Min Read

Taking action on opioid use disorder, pain & harm reduction during COVID-19

Policy recommendations focused on pain, opioid use disorder (OUD) and harm reduction to help states during the COVID-19 epidemic.

Behavioral Health
Car on empty railroad
·
3 Min Read

How to reignite the fight against the nation’s opioid epidemic

The COVID-19 crisis is far from over, yet the opioid epidemic continues to flare. The AMA details steps states should take, and calls on CDC to revise its opioid prescribing guideline.

Behavioral Health
·
5 Min Read

June 19, 2020: State Advocacy Update

AMA urges CDC to make significant revisions to opioid prescribing guideline and more State Advocacy news.

Advocacy Update